jmeb maintains the highest standards of article quality and publication ethics. We are committed to ensuring freedom of expression. The Editorial Board is the final deciding authority on all matters pertaining to publication and advertising; the decision should remain unaffected by any commercial revenue. Therefore, it is expected of all parties—editors, authors, reviewers, and the publisher—to adhere to standards of ethical behaviour. The Committee on Publication Ethics (COPE) served as the foundation for the development of the guidelines on publication ethics in jmeb.
We have been verifying the similarity of submitted manuscripts from 2021 using the iThenticate programme in association with CrossRef. When malpractice is reported, the Journal complies with the guidelines of the COPE flowchart. jmeb has a policy of not accepting articles with plagiarism, unclear authorship, or duplicate submissions for publication.
The article will be retracted and the author (and co-authors, if any), will not be allowed to submit any article again if any of the malpractices are found after its publication. If plagiarism is suspected, the author will be notified and a response will be expected by a specified date. The editor will get in touch with the author's organisation for additional research if they don't hear back within the specified amount of time.
If an author is to be added or removed from an article at any point, a signed declaration of agreement and an explanation for the change will have to be provided by each of the authors of that article including the author who wants to be added or removed.
jmeb does not publish studies involving animals if the animal board has not given clearance. Without the participant’s/patient's prior consent, no information about their identity should be released. All research involving human subjects should adhere to institutional and/or regional ethical guidelines and the 1975 Helsinki Declaration or National Ethical Guidelines for Biomedical and Health Research involving Human Participants (main.icmr.nic.in/sites/default/files/guidelines/ICMR_Ethical_Guidelines_2017.pdf).
It should be made clear in the text that the participant’s/patient’s consent has been acquired if the participant’s/patient's identity is disclosed in any way in the article. Since 2009, clinical studies conducted in India are required to register with the "Clinical Trials Registry - India" (http://ctri.nic.in/). It is a free online public record system that allows clinical studies carried out in India to be registered.
A scanned copy of the Ethical Clearance Certificate from the local or institutional ethics committee must be submitted by the author to the editorial board of the journal. The author should provide information about ethical approval in the Methodology section.
© 2024 jmeb. All rights reserved.
